YOU RECENTLY RECEIVED A NOTIFICATION REGARDING AN SGLT2I OR GLP-1 PRESCRIPTION FOR A T2D-RELATED GLYCEMIC CONTROL AGENT YOU WROTE FOR A SMITHRX MEMBER.
Consider prescribing generic dapagliflozin—the affordable SGLT2 inhibitor for glycemic control in type 2 diabetes (T2D) for your clinically appropriate patients with SmithRx.
1
Retail Pharmacy
Send a prescription for generic dapagliflozin to the patient’s preferred retail pharmacy.
2
Mail Order Delivery
For convenient mail order delivery: Cost Plus Drugs or Amazon Pharmacy
Questions?
Contact SmithRx: If you have any questions or need further assistance, including patient coverage or sending a new prescription, please contact the SmithRx Connect team at 844-385-7612.
<$15
Patient Copay for Your Patients Prescribed Generic Dapagliflozin for Glycemic Control in T2D
What is dapagliflozin?
Dapagliflozin (generic FARXIGA®) is an SGLT2 inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Not recommended for use in patients with type 1 diabetes mellitus.[1]
For additional information, click here.
What is the cost to patients?
<$15
copay to reduce cost barriers and to improve adherence
-
A copay of <$15 for generic dapagliflozin is consistent with the direct-to-consumer pricing models emerging in the pharmaceutical industry that prioritize patient affordability and support greater adherence for chronic condition treatment.
-
Substantial Plan Savings: The cost to the patient’s employer is significantly lower compared to other SGLT2 inhibitors and GLP-1s in the class.
-
Published list prices for GLP-1s used in T2D reach over $1000 per month.[2]
-
Branded SGLT2 inhibitors carry member copays of $45 to $50 per 30-day supply, compared with <$15 for generic dapagliflozin.
Brand | Preferred? | Mfg List Price*,† | Avg Copay‡ |
|---|---|---|---|
Dapagliflozin (generic)[1] | Yes | $240 § | <$15 |
FARXIGA® (dapagliflozin)[3] | No | $377.82 ‖ | $45 |
JARDIANCE® (empagliflozin)[4] | No | $350.00 ¶ | $45 |
INVOKANA® (canagliflozin)[5] | No | $592.57 # | $50 |
Cost does not imply a comparison of efficacy or safety.
* Cost based on a 30-day supply.
† Manufacturer list price, also called wholesale acquisition cost, is the price set by the manufacturer before rebates, discounts, or plan negotiation. It is not the amount paid by the plan or the member. List prices are subject to change and are accurate as of 7/14/26.
‡ Average patient out-of-pocket cost, including copay, based on a 30-day supply for SmithRx members. Varies by plan design.
§ $240 is an average based on published cash prices for a 30-day supply of generic dapagliflozin. No single manufacturer list price exists for a generic. Published prices range from $90 to $390 by dose and pharmacy (Drugs.com), with Cost Plus Drugs at approximately $390 and GoodRx reporting an average retail price of $413.87. Accurate as of July 2026.
‖ Based on a supply of 10 mg of FARXIGA.
¶ Based on a supply of 10 mg of JARDIANCE.
# Based on a supply of 100 mg of INVOKANA.
References:
-
Drugs.com. Dapagliflozin. Accessed July 20, 2026. https://www.drugs.com/pro/dapagliflozin.html
-
Amin K, Telesford I, Singh R. How do prices of drugs for weight loss in the US compare to peer nation’s prices? Peterson-KFF Health System Tracker. Accessed July 15, 2026. https://www.healthsystemtracker.org/brief/prices-of-drugs-for-weight-loss-in-the-us-and-peer-nations/
-
FARXIGA [prescribing information]. Wilmington, DE: AstraZeneca Pharmaceuticals.
-
JARDIANCE [prescribing information]. Ridgefield, CT: Boehringer lngelheim Pharmaceuticals, Inc.
-
INVOKANA [prescribing information]. Titusville, NJ: Janssen Pharmaceuticals, Inc.
Copyright 2026 QC-Health, Inc. All rights reserved.